# Proof of Concept Study Assessing Technology-Assisted Respiratory Adherence Prototype Version 3 in Individuals With COPD

> **NCT04795323** · PHASE2 · COMPLETED · sponsor: **Boehringer Ingelheim** · enrollment: 5 (actual)

## Conditions studied

- Pulmonary Disease, Chronic Obstructive

## Interventions

- **DEVICE:** TARA v3.1, only non-pharmacological self-management support
- **DEVICE:** TARA v3.2, both non-pharmacological and pharmacological self-management support

## Key facts

- **NCT ID:** NCT04795323
- **Lead sponsor:** Boehringer Ingelheim
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2021-04-08
- **Primary completion:** 2022-03-08
- **Final completion:** 2022-03-12
- **Target enrollment:** 5 (ACTUAL)
- **Last updated:** 2023-12-21


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04795323

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04795323, "Proof of Concept Study Assessing Technology-Assisted Respiratory Adherence Prototype Version 3 in Individuals With COPD". Retrieved via AI Analytics 2026-06-04 from https://api.ai-analytics.org/clinical/NCT04795323. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*